ILADS vs IDSA: The Lyme Disease Debate
ILADS and IDSA experts continue to disagree about Lyme disease.
The debate includes diagnosis, chronic symptoms, and treatment duration.
Differing guidelines have shaped patient care for decades.
Lyme in the Limelight, published by Hamodia, featured interviews with physicians, researchers, and advocacy leaders discussing disagreements surrounding Lyme disease diagnosis and treatment.
The article highlighted differing viewpoints between the Infectious Diseases Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS).
As a representative of IDSA and co-author of the organization’s Lyme disease guidelines, Dr. Eugene Shapiro described Lyme disease as generally straightforward to diagnose and treat.
I provided a different perspective as lead author of the ILADS Lyme disease treatment guidelines.
IDSA Perspective on Chronic Lyme Disease
Dr. Shapiro stated:
“Lyme disease is not difficult to diagnose and it’s a well-defined entity. It’s generally relatively easy to treat.”
He also questioned whether persistent symptoms following treatment are causally related to Lyme disease.
“To be clear, I believe that these patients suffer symptoms, but it’s not causally related to Lyme, or even to another medical condition.”
Dr. Shapiro additionally disputed the CDC’s estimate of approximately 300,000 annual Lyme disease cases in the United States and rejected the concept of chronic Lyme disease.
ILADS Perspective on Persistent Lyme Symptoms
ILADS has taken a different position regarding persistent symptoms and treatment considerations.
“The Lyme disease patient’s quality of life is the same or worse on standardized scales as diabetes, myocardial infarctions (heart attacks), fibromyalgia and chronic fatigue.”
ILADS guidelines also recommend a different approach to prophylactic treatment following certain tick bites.
“ILADS recommends that prophylactic treatment should be implemented for at least three weeks, with follow-up after a tick bite.”
The ILADS guidelines note that the study supporting a single 200-mg dose of doxycycline primarily evaluated prevention of erythema migrans rather than long-term manifestations of Lyme disease.
Why the Lyme Disease Debate Continues
The disagreement between ILADS and IDSA extends beyond treatment duration.
Areas of debate include:
- How Lyme disease should be diagnosed
- The interpretation of persistent symptoms after treatment
- The role of serologic testing
- The definition of chronic Lyme disease and PTLDS
- Whether treatment delays contribute to chronic illness
These differences continue to influence clinical care, insurance coverage, medical education, and patient experiences.
To learn more, visit persistent Lyme disease, Lyme test accuracy, and recovery from Lyme disease.
Clinical Perspective
The debate over Lyme disease diagnosis and treatment has persisted for decades.
For many patients, the controversy has real-world consequences involving delayed diagnosis, difficulty accessing care, and disagreement over the significance of persistent symptoms.
At the same time, researchers continue to investigate mechanisms that may contribute to prolonged neurologic, cognitive, autonomic, and musculoskeletal symptoms following Lyme disease.
(Source: Reprint permission given. Published in the print issue of Hamodia. For more information, visit hamodia.com.)
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
All I can say is thanks to Dr. Daniel Cameron and all the other Dr. Cameron out there who have stayed true to your oath as a doctor and persisted regardless of the peer pressure and legal pressure to turn away from the patients afflicted with tick borne illness!!! Also, I strongly hope that Dr. Shapiro is called out one day for his comments in this article and is made accountable. Sometimes words speak louder than actions and his case he has done it again and again. Time to come of the pedestal you put yourself on and admit – maybe just maybe I made a very big error!!!
Thank you Dr. Cameron for all you do. As for Mr. Shapiro. One day he will be counting up all those undiagnosed patients that died and MS and Alzheimer’s patients that could have been helped better with a better test and correct knowledge in the field of Lyme disease. It is my true gut feeling that Mr. Shapiro is more of a corporate man that patients caretaker. Unfortunately I have seen many doctors through the years chasing one diagnosis after the other. You get a good feel for the ones who wanted to be a Doctor for their patients and the ones who0 are in it for the big house and nice cars.